News Panacos Pharmaceuticals, Inc.

Equities

PANC

US69811Q1067

Delayed OTC Markets Other stock markets 12:48:54 24/04/2024 am IST			5-day change	1st Jan Change
0.000001 ^USD	-.--%		-.--%	-.--%

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Panacos Pharma : Panacos to Present at Bear Stearns Healthcare Conference	31/07/31	BU
Panacos Pharma : Panacos Reports Second Quarter 2007 Financial Results	01/07/01	BU
Panacos Pharma : Panacos Announces Five Presentations on its Antiviral Programs at International AIDS Society Conference	25/07/25	BU
Panacos Pharma : Panacos to Report Second Quarter Results for 2007	24/07/24	BU
Panacos Pharma : Panacos Secures $20 Million Debt Financing	29/07/29	BU
Panacos Pharma : Panacos Announces Substantial Antiviral Response in Bevirimat 250 mg Cohort, Data Support Further Dose Escalation in Phase 2b Study	21/07/21	BU
Panacos Pharma : Panacos to Present at Needham Biotech & Medtech Conference	06/07/06	BU
Panacos Pharma : Panacos to Present at Needham Biotech & Medtech Conference	06/07/06	BU
Panacos Pharma : Panacos to Present at Bear Stearns Biotech Confab	01/07/01	BU
Panacos Pharma : Preclinical Study Finds Protease Inhibitor-Resistant HIV May Have Reduced Potential to Develop Resistance to Panacos' Bevirimat	29/07/29	BU
Panacos Pharma : Panacos to Present at Bank of America Health Care Conference	23/07/23	BU
Panacos Pharma : Panacos Reports First Quarter 2007 Financial Results	03/07/03	BU
Panacos Pharma : Panacos to Present at Deutsche Bank Health Care Conference	27/07/27	BU
Panacos Pharma : Panacos to Report First Quarter Results for 2007	26/07/26	BU
Panacos Pharma : Panacos Announces New Board Member	16/07/16	BU
Panacos Pharma : Panacos to Present at CIBC World Markets Biotechnology & Specialty Pharmaceuticals Conference	04/07/04	BU
Panacos Pharma : Panacos Announces Bevirimat Phase 2b Dose Escalation Strategy	13/07/13	BU
Panacos Pharma : Panacos to Present at Citigroup Small & Mid-Cap Conference	08/07/08	BU
Panacos Pharma : Panacos to Present at Cowen Health Care Conference	06/07/06	BU
Panacos Pharma : Panacos Begins Phase 1 Clinical Study of Second Generation Maturation Inhibitor PA-040	27/07/27	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Panacos Pharmaceuticals, Inc.

Equities

PANC

US69811Q1067

Summary

Filters